ReCODE Program for Cognitive Decline

A Root-Cause, Precision-Based Approach at Dignity Medical

Cognitive decline is rarely caused by a single factor. It develops over time as inflammation, metabolic dysfunction, toxin exposure, hormonal imbalance, and impaired detoxification place increasing stress on the brain. As these issues compound, harmful proteins and inflammatory molecules circulate in the bloodstream, interfering with neuronal communication and accelerating cognitive aging.

At Dignity Medical in El Dorado Hills, we address these underlying drivers through the ReCODE® (Reversal of Cognitive Decline) Program—a personalized, science-backed approach designed to support memory, clarity, and long-term brain health. In select cases, therapeutic plasmapheresis may be integrated into a ReCODE plan to help reduce inflammatory burden and support systemic detoxification.

What Is the ReCODE® Program?

The ReCODE® Program, developed by Dr. Dale Bredesen, is built on the understanding that Alzheimer’s disease and cognitive decline are multifactorial conditions. Rather than managing symptoms alone, ReCODE focuses on identifying and correcting the biological imbalances that place the brain in a state of vulnerability.

Through advanced testing and clinical evaluation, the program assesses how factors such as inflammation, insulin resistance, vascular health, hormone levels, nutrient status, and toxic exposure are impacting brain function. Treatment is then tailored to address each patient’s specific drivers of decline, creating a comprehensive and individualized care plan.

How Plasmapheresis Supports Cognitive Health

One of the central objectives of the ReCODE Program is lowering chronic inflammation and reducing circulating toxins that impair neurological function. Over time, the plasma portion of the blood can accumulate inflammatory cytokines, oxidized proteins, autoantibodies, and other molecular debris that interfere with healthy brain signaling.

Therapeutic plasmapheresis, also known as Therapeutic Plasma Exchange (TPE), works by removing a portion of this compromised plasma and replacing it with a clean plasma substitute. When used appropriately within a ReCODE guided plan, plasmapheresis may help support:

• Reduction of systemic and neuroinflammatory markers

• Lower circulating toxic and oxidized proteins

• Improved immune system regulation

• A healthier biochemical environment for neuronal repair

• Enhanced response to other ReCODE interventions

Plasmapheresis is not a stand-alone treatment for cognitive decline. Instead, it is a supportive medical therapy used strategically when inflammation, immune activation, or toxic burden are identified as significant contributors.

Why This Matters for Brain Longevity

The brain is highly sensitive to the quality of the blood that nourishes it. When inflammatory or toxic molecules dominate circulation, synaptic communication, energy production, and cellular repair begin to suffer. Over time, this contributes to memory loss, brain fog, and cognitive slowing.

By addressing these upstream stressors, the ReCODE Program works to restore balance across the systems that support brain health. In this context, therapies that improve the internal biochemical environment, such as plasmapheresis, can play an important role in reducing the chronic signals that drive neurodegeneration.

Safety, Evaluation, and Personalized Care

At Dignity Medical, plasmapheresis is only considered after a thorough ReCODE evaluation. Each patient undergoes comprehensive lab testing, medical history review, and risk assessment to ensure the therapy is appropriate and aligned with their cognitive and longevity goals. All procedures are performed under strict clinical protocols and medical supervision.

An Integrated Approach to Cognitive Longevity

Plasmapheresis is one component of a broader ReCODE-based strategy at Dignity Medical. Treatment plans may also include targeted nutrition, lifestyle optimization, metabolic and hormone support, IV therapies, and ongoing cognitive monitoring. The goal is not just to slow decline, but to help patients maintain clarity, independence, and brain resilience as they age.